Results 41 to 50 of about 138,715 (220)

Association of sildenafil use with age-related macular degeneration: a retrospective cohort study

open access: yesBMJ Open Ophthalmology
Objective Despite significant advances in clinical care and understanding of the underlying pathophysiology, age-related macular degeneration (AMD)—a major cause of global blindness—lacks effective treatment to prevent the irreversible degeneration of ...
Nicola Jaime Adderley   +6 more
doaj   +1 more source

Diurnal variation of optical coherence tomography–based macular fluid in exudative age-related macular degeneration

open access: yesInternational Journal of Retina and Vitreous, 2023
Background Significant diurnal fluctuation of optical coherence tomography (OCT)-based macular fluid occurs in patients with several macular conditions including diabetic macular edema (DME) and cystoid macular edema due to retinal venous occlusion (RVO).
Blake H. Fortes   +5 more
doaj   +1 more source

The prevalence of age-related macular degeneration and osteoporosis in the older Polish population: Is there a link?

open access: yesPLoS ONE, 2023
BackgroundAge-related macular degeneration is the primary cause of irreversible blindness in developed countries, whereas the global prevalence of osteoporosis-a major public health problem-is 19.7%.
Agnieszka Budnik   +9 more
doaj   +1 more source

Acquired Vitelliform Macular Degeneration: Characteristics and Challenges of Managing Subretinal Fluid

open access: yesJournal of Ophthalmic & Vision Research, 2021
Purpose: To highlight diagnostic challenges in patients with acquired vitelliform macular degeneration (AVMD) with subretinal fluid (SRF) and to examine the characteristics of image findings in patients with AVMD.
Joseph Juliano   +2 more
doaj   +1 more source

Age-related macular degeneration: therapeutic modalities [PDF]

open access: yes, 2001
To describe the clinical and surgical therapeutic modalities in age-related macular degeneration (ARMD).Descrever as modalidades de tratamento clínico e cirúrgico das complicações da degeneração macular relacionada à idade (DMRI).Universidade Federal de ...
Costa, Rogerio Alves   +3 more
core   +2 more sources

Photo-damage, photo-protection and age-related macular degeneration [PDF]

open access: yes, 2015
Age-related macular degeneration (AMD) is a degenerative retinal disease that causes blindness in people 60-65 years and older, with the highest prevalence appearing in people 90 years-old or more.
Marquioni Ramella, Melisa Daniela   +1 more
core   +1 more source

Age-related macular degeneration [PDF]

open access: yesPostgraduate Medical Journal, 1998
Summary Macular degeneration is now responsible for approximately 95% of blindness and partial sighted registrations in the UK. This review has been written specifically to make the general medical community of the UK aware of the prevalence and clinical manifestations of aged-related macular degeneration. The review encompasses the risk
openaire   +2 more sources

Age Related Macular Degeneration

open access: yes, 2022
This paper is a literature review on the subject Age-Related Macular Degeneration (AMD) with a focus on its etiology, pathophysiology, clinical features, diagnosis, treatment, and prevention.
Hopsicker, Kathryn J
core  

Age-related macular degeneration: choroidal ischaemia? [PDF]

open access: yes, 2013
Aim: Our aim is to use ultrasound to non-invasively detect differences in choroidal microarchitecture possibly related to ischaemia among normal eyes and those with wet and dry age-related macular degeneration (AMD).
Chan, Robinson Vernon Paul   +5 more
core   +2 more sources

Neuroprotection for Age-Related Macular Degeneration

open access: yesOphthalmology Science, 2022
Age-related macular degeneration (AMD) is a leading cause of blindness worldwide. Early to intermediate AMD is characterized by the accumulation of lipid- and protein-rich drusen.
Jonathan B. Lin, MD, PhD   +3 more
doaj  

Home - About - Disclaimer - Privacy